Correction: Impact of Diffusion Barriers to Small Cytotoxic Molecules on the Efficacy of Immunotherapy in Breast Cancer

Correction: Impact of Diffusion Barriers to Small Cytotoxic Molecules on the Efficacy of Immunotherapy in Breast Cancer

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808440/?tool=EBI

Similar Items

Correction: Impact of Diffusion Barriers to Small Cytotoxic Molecules on the Efficacy of Immunotherapy in Breast Cancer.
by: Hiranmoy Das, et al.
Published: (2013-01-01)

Impact of diffusion barriers to small cytotoxic molecules on the efficacy of immunotherapy in breast cancer.
by: Hiranmoy Das, et al.
Published: (2013-01-01)

Small-molecule agents for cancer immunotherapy
by: Fang Wang, et al.
Published: (2024-03-01)

Small-Molecule PROTACs for Cancer Immunotherapy
by: Zefan Liu, et al.
Published: (2022-08-01)

Progress for Immunotherapy in Inflammatory Breast Cancer and Emerging Barriers to Therapeutic Efficacy
by: Regina M. Koch, et al.
Published: (2021-05-01)

Development of Small-Molecule STING Activators for Cancer Immunotherapy
by: Hee Ra Jung, et al.
Published: (2021-12-01)

Immunological barriers to immunotherapy in primary and metastatic breast cancer
by: Mara De Martino, et al.
Published: (2021-08-01)

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
by: Alaa M. Ghallab, et al.
Published: (2022-04-01)

Small-Molecule Targets in Tumor Immunotherapy
by: Hui-Fang Zhu, et al.
Published: (2018-07-01)

Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics
by: Mohd Wajid Ali Khan, et al.
Published: (2023-08-01)

Impact of cytotoxic T lymphocytes immunotherapy on prognosis of colorectal cancer patients
by: Yankun Zhu, et al.
Published: (2023-01-01)

Small molecule inhibitors for cancer immunotherapy and associated biomarkers – the current status
by: Lisa Schlicher, et al.
Published: (2023-10-01)

Correction: Advances in immunotherapy for triple-negative breast cancer
by: Yang Liu, et al.
Published: (2023-09-01)

Engineering small molecule nanodrugs to overcome barriers for cancer therapy
by: Yuan Ma, et al.
Published: (2020-09-01)

Correction: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer
Published: (2021-12-01)

Evaluation of Cytotoxic Activity of Small Aminated Quinolinequinones In Vitro as Anti-Cancer Molecules
by: Ayse Tarbin Jannuzzi, et al.
Published: (2022-11-01)

Editorial: Small molecules and smart drug delivery systems for combination cancer immunotherapy
by: Claudia Ferroni, et al.
Published: (2024-04-01)

Immunogenic cell death‐inducing small molecule inhibitors: Potential for immunotherapy of cancer
by: Zong Sheng Guo, et al.
Published: (2022-06-01)

Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in Glioblastoma
by: Jennifer K. Matsui, et al.
Published: (2022-07-01)

Overcoming Barriers of Age to Enhance Efficacy of Cancer Immunotherapy: The Clout of the Extracellular Matrix
by: Mark Owyong, et al.
Published: (2018-03-01)

Diffuse goitre enlargement after immunotherapy for non‐small cell lung cancer
by: Kohei Fujita, et al.
Published: (2021-11-01)

Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung Cancer
by: Amir Onn, et al.
Published: (2021-06-01)

Suppression of Breast Cancer by Small Molecules That Block the Prolactin Receptor
by: Dana C. Borcherding, et al.
Published: (2021-05-01)

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
by: Alexandr V. Bazhin, et al.
Published: (2018-12-01)

Efficacy of immunotherapy in oncogene-driven non-small-cell lung cancer
by: Natalie I. Vokes, et al.
Published: (2023-03-01)

Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy
by: Geethu S Kumar, et al.
Published: (2022-04-01)

Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery?
by: Peixin Du, et al.
Published: (2022-12-01)

Intracellular aggregation of peptide-reprogrammed small molecule nanoassemblies enhances cancer chemotherapy and combinatorial immunotherapy
by: Jinrong Peng, et al.
Published: (2021-04-01)

Barriers to Small Molecule Drug Discovery for Systemic Amyloidosis
by: Gareth J. Morgan
Published: (2021-06-01)

Searching for Small Molecules as Antibacterials: Non-Cytotoxic Diarylureas Analogues of Triclocarban
by: Alessia Catalano, et al.
Published: (2021-02-01)

A new class of pluripotent stem cell cytotoxic small molecules.
by: Mark Richards, et al.
Published: (2014-01-01)

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
by: Ke Xu, et al.
Published: (2020-05-01)

Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment
by: Binbin Cheng, et al.
Published: (2023-03-01)

Retrospective Analysis of the Clinical Characteristics of Patients with Breast Cancer Treated with Telomerase Peptide Immunotherapy Combined with Cytotoxic Chemotherapy
by: Kim JY, et al.
Published: (2023-12-01)

The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung Cancer
by: Deniz Can Guven, et al.
Published: (2023-12-01)

Recent Advancements in the Development of Anti-Breast Cancer Synthetic Small Molecules
by: Eslam B. Elkaeed, et al.
Published: (2021-12-01)

Small Molecules Targeting Programmed Cell Death in Breast Cancer Cells
by: Subashani Maniam, et al.
Published: (2021-09-01)

High-Throughput Microfluidic 3D Cytotoxicity Assay for Cancer Immunotherapy (CACI-IMPACT Platform)
by: Dohyun Park, et al.
Published: (2019-05-01)

Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy
by: Mohammad Fereydouni, et al.
Published: (2022-04-01)

Expansion of cancer germline antigen–specific cytotoxic T lymphocytes for immunotherapy
by: Deepa Kolaseri Krishnadas, et al.
Published: (2017-07-01)